Ciclosporin in the treatment of lupus nephritis

American Journal of Nephrology

Volumn 9, Issue , 1989, Pages 57-60

  Favre, H ^a,b   Miescher, P A ^a,b   Huang, Y P ^a,b   Chatelanat, F ^a,b   Mihatsch, M J ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Ciclosporin; Nephropathy; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE;

ADULT; CLINICAL ARTICLE; FEMALE; GLOMERULONEPHRITIS; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE;

ADULT; CLINICAL TRIALS; CYCLOSPORINS; DRUG THERAPY, COMBINATION; FEMALE; FLUOCORTOLONE; HUMAN; LUPUS NEPHRITIS; MALE;

EID: 0024571453     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168040     Document Type: Article

References (15)

1. Muchrcki, R.C., Kark, R.M., Pirani, C.L., Poltak, V.E.: Lupus nephritis. A clinical and pathological study based on renal biopsies. Medicine, Baltimore 35: 1-145 (1957).
2. Balow, J.E.: Lupus nephritis: natural history, prognosis and treatment. Clin. Immunol. Allergy 6: 353-365 (1986).
3. Cohen, P.L., Litvin, D.A., Winfield, J.B.: Association between endogenously activated T cells and immunoglobulin-secreting B cells in patients with active systemic lupus erythematosus. Arthritis Rheum. 25: 168-173 (1982).
4. Berenbaum, M.C., Brown, I.N.: Dose response relationships for agents inhibiting the immune response. Immunology 7: 65-71 (1964).
5. Mihatsch, M.J., Thiel, G., Ryffel, B.: Cyclosporin-associated nephropathy; in Schindler, Cyclosporin in autoimmune diseases. 1st Int. Symp. Basel, pp. 50-58 (Springer, Berlin 1985).
6. Miescher, P.A., Favre, H., Chatelanat, F., Mihatsch, M.J.: Combined steroid-cyclosporin treatment of chronic autoimmune diseases. Klin. Wschr. 65:127-136 (1987).
7. Favre, H.: Détermination des fonctions rénales par la technique de l’injection unique. Analyse statistique du modèle bicomparti-mental proposé par Sapirstein. J. Urol. Néphrol. 79: 1007-1052 (1973).
8. Hu, S.K., Mitcho, Y., Oronsky, A.L., Kerwar, S.S.: Studies on the effect of methotrexate on macrophage function. J. Rheumatol. 5: (in press).
9. Huang, Y.-P., Miescher, P.A., Zubler, R.H.: The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J. Immun. 137: 3515-3520 (1986).
10. Balow, J.E., Austin, H.A. III; Muenz, L.R., et al.: Effect of treatment on the evolution of renal abnormalities in lupus nephritis. New Engl. J. Med. 311: 491-495 (1984).
11. Amett, F.C., Reveille, J.D., Wilson, R.W., Provost, T.T., Bias, W.B.: Systemic lupus erythematosus: current state of the genetic hypothesis. Semin. Arthrit. Rheumatism 14: 24-35 (1984).
12. Weinstein, A.: Drug-induced systemic lupus erythematosus. Prog. clin. Immunol. 4: 1-21 (1980).
13. Zamansky, G.B.: Sunlight-induced pathogenesis in systemic lupus erythematosus (Editorial). J. invest. Derm. 85: 179-180 (1985).
14. Miescher, P.A., Favre, H., Mihatsch, M.J., Chatelanat, F., Huang, Y.P., Zubler, R.H.: The place of cyclosporine A in the treatment of connective tissue diseases. Proc. 2nd Int. Congr. Cyclosporine, Washington 1987. Transplant. Proc. (in press).
15. Favre, H., Miescher, P.A.: Filtration fraction: an index of the renal disease activity in SLE patients; in Davison, Guillon, Proc. EDTA, vol. 21, pp. 717-721 (Pitman, Bath 1984).